Oocyte cryopreservation for fertility preservation in girls whose fertility is expected to decline
Not Applicable
- Conditions
- Malignant disease, blood diseases, collagen diseases, Turner syndrome, ovarian tumors, and other diseases where ovarian reserve is expected to decline due to the underlying disease or treatment.
- Registration Number
- JPRN-UMIN000052857
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
If the attending physician deems it inappropriate If oocyte cryopreservation is judged to be dangerous due to poor physical condition, blood, or general condition. When the prognosis is extremely poor If the person and his or her family do not agree
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the number of oocytes retrieved, the number of mature oocytes, the number of pregnancies, and the patient's long-term ovarian reserve. The presence of ovarian hyperstimulation syndrome, infection and abnormal bleeding, and changes in mental status will also be evaluated.
- Secondary Outcome Measures
Name Time Method Short-term and long-term ovarian reserve (AMH, FSH, E2, menstruation, etc.)